Community consultation: Not the problem - An important part of the solution

American Journal of Bioethics

Volumn 6, Issue 3, 2006, Pages 26-28

  Dickert, Neal ^a   Sugarman, Jeremy ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN; POLYMERIZED HEMOGLOBIN;

CLINICAL TRIAL; CONSUMER; CONTROLLED CLINICAL TRIAL; ETHICS; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; METHODOLOGY; MINORITY GROUP; PERSONAL AUTONOMY; PUBLIC OPINION; PUBLIC RELATIONS; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; SHORT SURVEY; UNITED STATES;

BLOOD SUBSTITUTES; COMMUNITY-INSTITUTIONAL RELATIONS; CONSUMER PARTICIPATION; DISCLOSURE; ETHICS, RESEARCH; HEMOGLOBINS; HUMANS; INFORMED CONSENT; MINORITY GROUPS; NEGOTIATING; NORTH CAROLINA; PERSONAL AUTONOMY; PUBLIC OPINION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; UNITED STATES;

EID: 33745109239     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160600685762     Document Type: Short Survey

References (6)

1. Dickert, N. W., and J. Sugarman. 2005. Ethical goals of community consultation in research. American Journal of Public Health 95(7): 1123-1127.
2. Holloway, K. F. C. 2006. Accidental Communities: Race, emergency medicine, and the problem of PolyHeme®. American Journal of Bioethics 6(3): 7-17.
3. Kipnis, K., N. M. P. King, and R. M. Nelson. 2006. An open letter to institutional review boards considering Northfield Laboratories' PolyHeme® trial. American Journal of Bioethics 6(3): 18-21.
4. Kremers, M. S., D. R. Whisnant, L. S. Lowder, and L. Gregg. 1999. Initial experience using the Food and Drug Administration guidelines for emergency research without consent. Annals of Emergency Medicine 33(2): 221-229.
5. MacQueen, K. M., E. McLellan, D. S. Metzger, S. Kegeles, R. P. Strauss, R. Scotti, L. Blanchard, R. T. Trotter 2nd. 2001. What is community? An evidence-based definition for participatory public health. American Journal of Public Health 91(12): 1929-1938.
6. U.S. Food and Drug Administration. 2001. Exception from informed consent requirements for emergency research. Title 20, Code of Federal Regulations, 50.24.